DUPILUMAB EFFICACY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND SEROLOGIC EVIDENCE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS

被引：10
|
作者：
Corren, J.
Sher, L.
Zhu, X.
Rice, M.
Deniz, Y.
Rowe, P.
Staudinger, H.
Ruddy, M.
Patel, N.
Graham, N.
Teper, A.
Amin, N.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.071
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D201
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
    Corren, Jonathan
    Jackson, David J.
    Casale, Thomas B.
    Borish, Larry
    Rabe, Klaus F.
    Busse, William W.
    Maspero, Jorge F.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Altincatal, Arman
    Radwan, Amr
    Khodzhayev, Angela
    Djandji, Michel
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 249 - 260
  • [22] Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Arima, Kazuhiko
    Miyata, Masanori
    Takahashi, Yoshinori
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Patel, Naimish
    Graham, Neil M. H.
    Teper, Ariel
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 578 - 587
  • [23] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [24] Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype
    Rabe, Klaus F.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Castro, Mario
    Pavord, Ian D.
    Maspero, Jorge F.
    Busse, William W.
    Izuhara, Kenji
    Daizadeh, Nadia
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Rowe, Paul J.
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 2916 - +
  • [25] Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma
    Papadopoulos, Nikolaos G. G.
    Szefler, Stanley J. J.
    Bacharier, Leonard B. B.
    Maspero, Jorge F. F.
    Domingo, Christian
    Fiocchi, Alessandro
    Lee, Jason K. K.
    Daizadeh, Nadia
    Lederer, David J. J.
    Hardin, Megan
    Gall, Rebecca
    Djandji, Michel
    Siddiqui, Shahid
    Jacob-Nara, Juby A. A.
    Deniz, Yamo
    Rowe, Paul J. J.
    ALLERGY, 2023, 78 (08) : 2157 - 2167
  • [26] Dupilumab in moderate-to-severe asthma
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 209 - 209
  • [27] Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
    Hanania, Nicola A.
    Castro, Mario
    Bateman, Eric
    Pavord, Ian D.
    Papi, Alberto
    FitzGerald, J. Mark
    Maspero, Jorge F.
    Katelaris, Constance H.
    Singh, Dave
    Daizadeh, Nadia
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Laws, Elizabeth
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (02) : 206 - 214.e2
  • [28] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction
    Hanania, N. A.
    Castro, M.
    Bateman, E. D.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Daizadeh, N.
    Pandit-Abid, N.
    Ortiz, B.
    Laws, E.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Lederer, D. J.
    Hardin, M.
    Siddiqui, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [30] Dupilumab Efficacy and Safety in Children with Uncontrolled, Moderate-to-Severe Asthma: The Phase 3 VOYAGE Study
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I
    Jain, N.
    Sher, L. D.
    Mao, X.
    Liu, D.
    Zhang, Y.
    Khan, A. H.
    Kapoor, U.
    Khokhar, F. A.
    Rowe, P.
    Deniz, Y.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Mannent, L. P.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345